Pneumococcal Vaccination Strategies in 50-Year-Olds to Decrease Racial Disparities: A US Societal Perspective Cost-Effectiveness Analysis
Shoroq M. Altawalbeh, Angela R. Wateska, Mary Patricia Nowalk, Chyongchiou J. Lin, Lee H. Harrison, William Schaffner, Richard K. Zimmerman, Kenneth J. Smith
Topics & Concepts
Pneumococcal conjugate vaccineMedicineVaccinationPneumococcal polysaccharide vaccineDemographyCost effectivenessPopulationQuality-adjusted life yearCost-effectiveness analysisEnvironmental healthImmunologyPneumococcal diseaseStreptococcus pneumoniaeBacteriaSociologyBiologyGeneticsRisk analysis (engineering)Pneumonia and Respiratory InfectionsRespiratory viral infections researchImmune responses and vaccinations